[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

North America Pneumonia Vaccines Market (2019-2025)

June 2019 | 90 pages | ID: NABD8E1DDBBEN
KBV Research

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The North America Pneumonia Vaccines Market would witness market growth of 3.7% CAGR during the forecast period (2019–2025).

Pneumococcal disease is an infection which is caused by the Streptococcus pneumoniae bacteria, also called pneumococcus. Pneumococcal diseases range from mild to very severe. When the bacteria spread from the nose and throat to ears or sinuses, it causes mild infections. When it further spreads into other parts of the body, it leads to severe health problems like pneumonia, bacteremia, and meningitis. These ailments are often deadly, especially for adults 65 years or older, people with chronic health conditions, and individuals whose immune systems are weakened by disease or medicines (immunocompromised). The diseases also lead to disabilities like brain damage, deafness, or loss of arms or legs.

Every year in the United States, pneumonia kills thousands of adults. Many more adults end up in the hospital due to this disease. It can cause severe infections of the lungs (pneumonia), bloodstream (bacteremia), and lining of the brain and spinal cord (meningitis). Vaccines like PCV13 are the best solution which protects against 13 strains of pneumococcal bacteria and PPSV23 protects against 23 strains of pneumococcal bacteria. Both the vaccines ensure protection from illnesses like meningitis and bacteremia.

Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. and MERCK & CO., Inc.

Scope of the Study

Market Segmentation:

By Vaccine Type
  • Pneumococcal conjugate vaccine (PCV)
  • Pneumococcal polysaccharide vaccine (PPSV/PPV)
By Product Type
  • Prevnar 13
  • Synflorix
  • Pneumovax23
By Sector
  • Public sector
  • Private sector
By Distribution Channel
  • Distribution partner companies
  • Non-governmental Organizations (NGO)
  • Government Authorities
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Glaxosmithkline Plc. (GSK)
  • LG Corporation
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Pnuvax Incorporated
  • Poonawalla Investments & Industries Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd.
  • SK Holdings Co., Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Merck & Co., Inc.
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 North America Pneumonia Vaccines Market, by Vaccine Type
  1.4.2 North America Pneumonia Vaccines Market, by Product Type
  1.4.3 North America Pneumonia Vaccines Market, by Sector
  1.4.4 North America Pneumonia Vaccines Market, by Distribution Channel
  1.4.5 North America Pneumonia Vaccines Market, by Country
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. NORTH AMERICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE

3.1 North America Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 North America Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region

CHAPTER 4. NORTH AMERICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE

4.1 North America Prevnar 13 Market by Region
4.2 North America Synflorix Market by Region
4.3 North America Pneumovax 23 Market by Region

CHAPTER 5. NORTH AMERICA PNEUMONIA VACCINES MARKET BY SECTOR

5.1 North America Private sector Market by Region
5.2 North America Public sector Market by Region

CHAPTER 6. NORTH AMERICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL

6.1 North America Distribution Partner Companies Market by Region
6.2 North America Non-Governmental Organizations (NGO) Market by Region
6.3 North America Government Authorities Market by Region

CHAPTER 7. NORTH AMERICA PNEUMONIA VACCINES MARKET BY COUNTRY

7.1 USA Pneumonia Vaccines Market
  7.1.1 USA Pneumonia Vaccines Market by Vaccine Type
  7.1.2 USA Pneumonia Vaccines Market by Product Type
  7.1.3 USA Pneumonia Vaccines Market by Sector
  7.1.4 USA Pneumonia Vaccines Market by Distribution Channel
7.2 Canada Pneumonia Vaccines Market
  7.2.1 Canada Pneumonia Vaccines Market by Vaccine Type
  7.2.2 Canada Pneumonia Vaccines Market by Product Type
  7.2.3 Canada Pneumonia Vaccines Market by Sector
  7.2.4 Canada Pneumonia Vaccines Market by Distribution Channel
7.3 Mexico Pneumonia Vaccines Market
  7.3.1 Mexico Pneumonia Vaccines Market by Vaccine Type
  7.3.2 Mexico Pneumonia Vaccines Market by Product Type
  7.3.3 Mexico Pneumonia Vaccines Market by Sector
  7.3.4 Mexico Pneumonia Vaccines Market by Distribution Channel
7.4 Rest of North America Pneumonia Vaccines Market
  7.4.1 Rest of North America Pneumonia Vaccines Market by Vaccine Type
  7.4.2 Rest of North America Pneumonia Vaccines Market by Product Type
  7.4.3 Rest of North America Pneumonia Vaccines Market by Sector
  7.4.4 Rest of North America Pneumonia Vaccines Market by Distribution Channel

CHAPTER 8. COMPANY PROFILES

8.1 GLAXOSMITHKLINE PLC (GSK)
  8.1.1 Company Overview
  8.1.2 Financial Analysis
  8.1.3 Segmental and Regional Analysis
  8.1.4 Research & Development Expense
  8.1.1 Recent strategies and developments:
    8.1.1.1 Collaboration, partnerships and agreements:
    8.1.1.2 Expansion:
  8.1.2 SWOT Analysis
8.2 LG Corporation (LG Chemicals Ltd.)
  8.2.1 Company Overview
  8.2.2 Financial Analysis
  8.2.3 Segmental and Regional Analysis
  8.2.4 Research & Development Expense
  8.2.5 SWOT Analysis
8.3 Panacea Biotec Limited
  8.3.1 Company Overview
  8.3.2 Financial Analysis
  8.3.3 Segmental and Regional Analysis
  8.3.4 Research & Development Expense
  8.3.5 Recent strategies and developments:
    8.3.5.1 Collaboration, partnerships and agreements:
  8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
  8.4.1 Company Overview
  8.4.2 Financial Analysis
  8.4.3 Segmental and Regional Analysis
  8.4.4 Research & Development Expense
  8.4.5 Recent strategies and developments:
    8.4.5.1 Collaboration, partnerships and agreements:
    8.4.5.2 Product launch:
  8.4.6 SWOT Analysis
8.5 PnuVax Incorporated
  8.5.1 Company Overview
8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
  8.6.1 Company Overview
8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
  8.7.1 Company Overview
8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
  8.8.1 Company overview
  8.8.2 Financial Analysis
  8.8.3 Segmental and Regional Analysis
  8.8.4 Research & Development Expenses
8.9 Walvax Biotechnology Co., Ltd.
  8.9.1 Company Overview
  8.9.2 Recent strategies and developments:
    8.9.2.1 Product launch:
8.1 Merck & Co., Inc.
  8.10.1 Company Overview
  8.10.2 Financial Analysis
  8.10.3 Segmental and Regional Analysis
  8.10.4 Research & Development Expenses
  8.10.5 Recent strategies and developments:
    8.10.5.1 Collaboration, partnerships and agreements:
    8.10.5.2 Product launch:
  8.10.6 SWOT Analysis

LIST OF TABLES

TABLE 1 NORTH AMERICA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
TABLE 3 NORTH AMERICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 29 NORTH AMERICA GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 NORTH AMERICA GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 NORTH AMERICA PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 NORTH AMERICA PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 USA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 34 USA PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
TABLE 35 USA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 36 USA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 37 USA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 38 USA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 39 USA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 40 USA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 41 USA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 USA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 CANADA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 44 CANADA PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
TABLE 45 CANADA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 46 CANADA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 47 CANADA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 48 CANADA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 49 CANADA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 50 CANADA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 51 CANADA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 CANADA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 MEXICO PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 54 MEXICO PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
TABLE 55 MEXICO PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 56 MEXICO PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 57 MEXICO PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 58 MEXICO PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 59 MEXICO PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 60 MEXICO PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 61 MEXICO PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 62 MEXICO PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 63 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
TABLE 64 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET, 2018 - 2024, USD MILLION
TABLE 65 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
TABLE 66 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
TABLE 67 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
TABLE 68 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
TABLE 69 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
TABLE 70 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
TABLE 71 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 72 REST OF NORTH AMERICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 73 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 74 KEY INFORMATION – LG CORPORATION
TABLE 75 KEY INFORMATION – PANACEA BIOTEC LIMITED
TABLE 76 KEY INFORMATION – PFIZER, INC.
TABLE 77 KEY INFORMATION – PNUVAX INCORPORATED
TABLE 78 KEY INFORMATION – POONAWALLA INVESTMENTS & INDUSTRIES PVT. LTD.
TABLE 79 KEY INFORMATION – SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
TABLE 80 KEY INFORMATION – SK HOLDINGS CO., LTD.
TABLE 81 KEY INFORMATION – WALVAX BIOTECHNOLOGY CO., LTD.
TABLE 82 KEY INFORMATION - MERCK & CO., INC.

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH


More Publications